Mozart Therapeutics
Mozart Therapeutics is developing CD8 Treg modulators for the treatment of autoimmune and inflammatory diseases.
$25M Series A ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
X account@Mozart_tx · created Oct 5, 2021 (5 years old) · 30 followers
Website registeredJun 24, 2020 (6 years old)
TIMELINE · MONEY RAISED
Mozart Therapeutics | 489 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $25M | — | fundraisingfox.com | |
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
CK
Calvin Kuo Scientific Co-Foundersource: mozart-tx.comGT
Gerald T. Nepom Scientific Co-Foundersource: mozart-tx.comKC
K. Christopher Garcia Scientific Co-Foundersource: mozart-tx.comMD
Mark Davis Scientific Co-Foundersource: mozart-tx.comMR
Michael Rosenblum Scientific Co-Foundersource: mozart-tx.com
Companies like Mozart Therapeutics
FFlip TherapeuticsSeed · Sep 2026
DDren Bio$350M Series B+ · Oct 2026MMerida Biosciences$120M Series A · May 2025
KKinaset Therapeutics$103M Series B+ · Jan 2026
AAltruBio$225M Series B+ · May 2024
SSynthekine$100M Series B+ · Jan 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mozart-therapeutics (get a free API key).